Evidence mapPaperPMID 41401666Full record

Observational studyPediatric neurology2026

Six-Minute Activity-95

Nicholas Joy, Jonathan Soslow, W Bryan Burnette, Andrew Liu, Christine C Guo, Rakesh Pilkar, James C Slaughter, Meng Xu, Kimberly Crum, Karry Su and 9 more

Abstract readObservational Study
In one paragraph

Observational study in Pediatric neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Nicholas JoyDivision of Pediatric Cardiology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: nicholas.joy@vumc.org.
Jonathan SoslowDivision of Pediatric Cardiology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
W Bryan BurnetteDivision of Pediatric Neurology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
Andrew LiuAmetris, L.L.C., Pensacola, Florida.
Christine C GuoAmetris, L.L.C., Pensacola, Florida.
Rakesh PilkarAmetris, L.L.C., Pensacola, Florida.
James C SlaughterDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
Meng XuDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
Kimberly CrumDivision of Pediatric Cardiology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
Karry SuDivision of Pediatric Cardiology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
Christopher SpurneyChildren's National Heart Institute, Children's National Hospital, Washington, District of Columbia.
Nazia HusainDivision of Cardiology, Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Katheryn GambettaDivision of Cardiology, Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Brian D SorianoDivision of Cardiology, Department of Pediatrics, Seattle Children's Hospital, University of Washington School of Medicine, Seattle, Washington.
Frank J RaucciDivision of Cardiology, Department of Pediatrics, Children's Hospital of Richmond at VCU, Richmond, Virginia.
Kan HorDivision of Pediatric Cardiology, Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio.
Larry W MarkhamDivision of Pediatric Cardiology, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana.
Jaclyn TamaroffDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
DMDCCC Investigators

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR002243 · VANDERBILT UNIVERSITY MEDICAL CENTER · 2025 to 2025
$10.7M
Phase 2 Study of Theophylline for the Treatment of PsuedohypoparathyroidismR01DK118407 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · 2022 to 2025
$2.5M
Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug TrialsR01HL167969 · VANDERBILT UNIVERSITY MEDICAL CENTER · 2025 to 2025
$738k
Targeting Pannexin 1 as a Novel Mechanism for Arrhythmia and Fibrosis in Duchenne CardiomyopathyK08HL155852 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · 2022 to 2025
$593k
FDA HHS R01 FD006649NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1 TR002243NHLBI NIH HHS K08 HL155852NHLBI NIH HHS K23 HL123938NHLBI NIH HHS R01 HL167969NHLBI NIH HHS R56 HL141248NIDDK NIH HHS R01 DK118407
6 · The paper itself

Abstract

backgroundThe six-minute walk test and quantitative muscle testing (QMT) are commonly used skeletal muscle assessments in Duchenne muscular dystrophy; however, they present challenges in nonambulatory patients. Our objective was to evaluate whether 6-min activity-95

methodsParticipants (N = 139) in an observational, longitudinal natural history study with median age of 12.0 years [interquartile range 10.0, 15.0] completed muscle testing and were instructed to wear an accelerometer on dominant wrist for 7 days and nights (a "wear") at each of three annual study visits. One hundred two male participants were analyzed with a total of 184 valid wear periods.

resultsSix-minute activity centiles declined over 2 years (n = 28, P < 0.001). No significant declines in centiles were detected immediately following loss of ambulation (n = 11). Significant correlations were observed between 6-min activity centiles and indexed QMT, with strongest at 95

conclusionsAmbulatory and nonambulatory patients with Duchenne muscular dystrophy were differentiated by 6-min activity and declined over time, modeling progression of skeletal myopathy. Six-minute activity-95

Indexed as

AccelerometryMuscular Dystrophy, DuchenneOutcome Assessment, Health CareWearable Electronic DevicesAdolescentChildHumansLongitudinal StudiesMaleWalk TestAccelerometryAmbulationClinical outcome assessmentDuchenne muscular dystrophy

Identifiers

PMID41401666
PMCPMC13306447

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.